Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics
- 1 September 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 15 (9), 1410-1416
- https://doi.org/10.1002/ibd.20943
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM StudyGastroenterology, 2008
- Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel DiseaseGastroenterology, 2008
- Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosisGut, 2007
- Sustained improvement of health-related quality of life in Crohnʼs disease patients treated with infliximab and azathioprine for 4 yearsInflammatory Bowel Diseases, 2007
- The Effects of Infliximab Therapy on Health-Related Quality of Life in Ulcerative Colitis PatientsThe American Journal of Gastroenterology, 2007
- Patients with Inflammatory Bowel Disease Are at Risk for Vaccine-Preventable IllnessesThe American Journal of Gastroenterology, 2006
- Influenza Vaccination of Patients With Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA)Clinical and Developmental Immunology, 2006
- A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on AzathioprineGastroenterology, 2005
- Disseminated Primary Varicella after Initiation of Infliximab for Crohn's DiseaseThe American Journal of Gastroenterology, 2004
- Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxisGut, 2004